About
Metallomix, Inc. was formerly known as Nomax Therapeutics, Inc. Metallomix is a pioneering biotech company dedicated to developing truly novel medicines by studying isotopic fractionation in cells and tissues and creating safe, effective isotope-selective modulators that target scientifically validated pathways. Focusing on the roles of metals and isotopic fractions in human physiology, particularly in inflammation and oxidative stress, Metallomix seeks to restore the balance between cellular homeostasis and the body’s inflammatory and oxidative responses. By precisely modulating cellular processes with non-radioactive isotopes, the company aims to deliver safer and more effective treatments for oncological and age-related diseases.
MiamiresearchBiotechnology